1-8 of 8
Katherine R. Kozak
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Calicheamicin Antibody–Drug Conjugates with Improved Properties

Available to Purchase
Breanna S. Vollmar, Chris Frantz, Melissa M. Schutten, Fiona Zhong, Geoffrey del Rosario, Mary Ann T. Go, Shang-Fan Yu, Douglas D. Leipold, Amrita V. Kamath, Carl Ng, Keyang Xu, Josefa dela Cruz-Chuh, Katherine R. Kozak, Jinhua Chen, Zijin Xu, John Wai, Pragya Adhikari, Hans K. Erickson, Peter S. Dragovich, Andrew G. Polson, Thomas H. Pillow
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (6): 1112–1120.
https://doi.org/10.1158/1535-7163.MCT-20-0035
Published: 01 June 2021
View articletitled, Calicheamicin Antibody–Drug Conjugates with Improved Properties
Open the PDF for Calicheamicin Antibody–Drug Conjugates with Improved Properties in another window
Includes: Supplementary data
Journal Articles

Correction: An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody–Drug Conjugate for the Treatment of Hormone Receptor–Positive Breast Cancer

Free
Sunil Bhakta, Lisa M. Crocker, Yvonne Chen, Meredith Hazen, Melissa M. Schutten, Dongwei Li, Coenraad Kuijl, Rachana Ohri, Fiona Zhong, Kirsten A. Poon, Mary Ann T. Go, Eric Cheng, Robert Piskol, Ron Firestein, Aimee Fourie-O'Donohue, Katherine R. Kozak, Helga Raab, Jo-Anne Hongo, Deepak Sampath, Mark S. Dennis, Richard H. Scheller, Paul Polakis, Jagath R. Junutula
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (11): 2182.
https://doi.org/10.1158/1535-7163.MCT-19-0749
Published: 01 November 2019
View articletitled, Correction: An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody–Drug Conjugate for the Treatment of Hormone Receptor–Positive Breast Cancer
Open the PDF for Correction: An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody–Drug Conjugate for the Treatment of Hormone Receptor–Positive Breast Cancer in another window
Journal Articles

Intratumoral Payload Concentration Correlates with the Activity of Antibody–Drug Conjugates

Free
Donglu Zhang, Shang-Fan Yu, S. Cyrus Khojasteh, Yong Ma, Thomas H. Pillow, Jack D. Sadowsky, Dian Su, Katherine R. Kozak, Keyang Xu, Andrew G. Polson, Peter S. Dragovich, Cornelis E.C.A. Hop
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (3): 677–685.
https://doi.org/10.1158/1535-7163.MCT-17-0697
Published: 28 February 2018
View articletitled, Intratumoral Payload Concentration Correlates with the Activity of Antibody–Drug Conjugates
Open the PDF for Intratumoral Payload Concentration Correlates with the Activity of Antibody–Drug Conjugates in another window
Includes: Supplementary data
Journal Articles

An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody–Drug Conjugate for the Treatment of Hormone Receptor–Positive Breast Cancer

Free
Sunil Bhakta, Lisa M. Crocker, Yvonne Chen, Meredith Hazen, Melissa M. Schutten, Dongwei Li, Coenraad Kuijl, Rachana Ohri, Fiona Zhong, Kirsten A. Poon, Mary Ann T. Go, Eric Cheng, Robert Piskol, Ron Firestein, Aimee Fourie-O'Donohue, Katherine R. Kozak, Helga Raab, Jo-Anne Hongo, Deepak Sampath, Mark S. Dennis, Richard H. Scheller, Paul Polakis, Jagath R. Junutula
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2018) 17 (3): 638–649.
https://doi.org/10.1158/1535-7163.MCT-17-0813
Published: 28 February 2018
View articletitled, An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody–Drug Conjugate for the Treatment of Hormone Receptor–Positive Breast Cancer
Open the PDF for An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody–Drug Conjugate for the Treatment of Hormone Receptor–Positive Breast Cancer in another window
Includes: Supplementary data
Journal Articles

An Antimesothelin-Monomethyl Auristatin E Conjugate with Potent Antitumor Activity in Ovarian, Pancreatic, and Mesothelioma Models

Free
Suzie J. Scales, Nidhi Gupta, Glenn Pacheco, Ron Firestein, Dorothy M. French, Hartmut Koeppen, Linda Rangell, Vivian Barry-Hamilton, Elizabeth Luis, Josefa Chuh, Yin Zhang, Gladys S. Ingle, Aimee Fourie-O'Donohue, Katherine R. Kozak, Sarajane Ross, Mark S. Dennis, Susan D. Spencer
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2014) 13 (11): 2630–2640.
https://doi.org/10.1158/1535-7163.MCT-14-0487-T
Published: 03 November 2014
View articletitled, An Antimesothelin-Monomethyl Auristatin E Conjugate with Potent Antitumor Activity in Ovarian, Pancreatic, and Mesothelioma Models
Open the PDF for An Antimesothelin-Monomethyl Auristatin E Conjugate with Potent Antitumor Activity in Ovarian, Pancreatic, and Mesothelioma Models in another window
Includes: Supplementary data
Journal Articles

DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody–Drug Conjugate, Is a Potential Treatment for Non-Hodgkin Lymphoma

Free
Dongwei Li, Kirsten Achilles Poon, Shang-Fan Yu, Randall Dere, MaryAnn Go, Jeffrey Lau, Bing Zheng, Kristi Elkins, Dimitry Danilenko, Katherine R. Kozak, Pamela Chan, Josefa Chuh, Xiaoyan Shi, Denise Nazzal, Franklin Fuh, Jacqueline McBride, Vanitha Ramakrishnan, Ruth de Tute, Andy Rawstron, Andrew S. Jack, Rong Deng, Yu-Waye Chu, David Dornan, Marna Williams, William Ho, Allen Ebens, Saileta Prabhu, Andrew G. Polson
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (7): 1255–1265.
https://doi.org/10.1158/1535-7163.MCT-12-1173
Published: 07 July 2013
View articletitled, DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody–Drug Conjugate, Is a Potential Treatment for Non-Hodgkin Lymphoma
Open the PDF for DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody–Drug Conjugate, Is a Potential Treatment for Non-Hodgkin Lymphoma in another window
Includes: Supplementary data
Journal Articles

Effects of Anti-VEGF on Pharmacokinetics, Biodistribution, and Tumor Penetration of Trastuzumab in a Preclinical Breast Cancer Model

Free
Cinthia V. Pastuskovas, Eduardo E. Mundo, Simon P. Williams, Tapan K. Nayak, Jason Ho, Sheila Ulufatu, Suzanna Clark, Sarajane Ross, Eric Cheng, Kathryn Parsons-Reponte, Gary Cain, Marjie Van Hoy, Nicholas Majidy, Sheila Bheddah, Josefa dela Cruz Chuh, Katherine R. Kozak, Nicholas Lewin-Koh, Peter Nauka, Daniela Bumbaca, Mark Sliwkowski, Jay Tibbitts, Frank-Peter Theil, Paul J. Fielder, Leslie A. Khawli, C. Andrew Boswell
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (3): 752–762.
https://doi.org/10.1158/1535-7163.MCT-11-0742-T
Published: 06 March 2012
View articletitled, Effects of Anti-VEGF on Pharmacokinetics, Biodistribution, and Tumor Penetration of Trastuzumab in a Preclinical Breast Cancer Model
Open the PDF for Effects of Anti-VEGF on Pharmacokinetics, Biodistribution, and Tumor Penetration of Trastuzumab in a Preclinical Breast Cancer Model in another window
Includes: Supplementary data
Journal Articles

In vivo effects of targeting CD79b with antibodies and antibody-drug conjugates

Free
Bing Zheng, Reina N. Fuji, Kristi Elkins, Shang-Fan Yu, Franklin K. Fuh, Josefa Chuh, Christine Tan, Jo-Anne Hongo, Helga Raab, Katherine R. Kozak, Marna Williams, Elena McDorman, Dan Eaton, Allen Ebens, Andrew G. Polson
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (10): 2937–2946.
https://doi.org/10.1158/1535-7163.MCT-09-0369
Published: 12 October 2009
View articletitled, In vivo effects of targeting CD79b with antibodies and antibody-drug conjugates
Open the PDF for In vivo effects of targeting CD79b with antibodies and antibody-drug conjugates in another window